𝔖 Bobbio Scriptorium

✦ LIBER ✦

Good Research Practices for Measuring Drug Costs in Cost Effectiveness Analyses: Issues and Recommendations: The ISPOR Drug Cost Task Force Report—Part I

✍ Scribed by Joel W. Hay; Jim Smeeding; Norman V. Carroll; Michael Drummond; Louis P. Garrison; Edward C. Mansley; C. Daniel Mullins; Jack M. Mycka; Brian Seal; Lizheng Shi

Book ID: 109079114
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 71 KB
Volume: 13
Category: Article
ISSN: 1098-3015
DOI: 10.1111/j.1524-4733.2009.00663.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Good Research Practices for Measuring Dr

Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Societal Perspective: The ISPOR Drug Cost Task Force Report—Part II

✍ Louis P. Garrison Jr.; Edward C. Mansley; Thomas A. Abbott III; Brian W. Bresnah 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB

Good Research Practices for Measuring Dr

Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: An International Perspective: The ISPOR Drug Cost Task Force Report—Part VI

✍ Lizheng Shi; Meredith Hodges; Michael Drummond; Jeonghoon Ahn; Shu Chuen Li; Sha 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

Good Research Practices for Measuring Dr

Good Research Practices for Measuring Drug Costs in Cost Effectiveness Analyses: An Industry Perspective: The ISPOR Drug Cost Task Force Report—Part V

✍ Jack M. Mycka; Renato Dellamano; Eugene Mick Kolassa; Michael Wonder; Sabyasachi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Good Research Practices for Measuring Dr

Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Managed Care Perspective: The ISPOR Drug Cost Task Force Report—Part III

✍ Edward C. Mansley; Norman V. Carroll; Kristina S. Chen; Nilay D. Shah; Catherine 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

Good Research Practices for Measuring Dr

Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: Medicare, Medicaid and Other US Government Payers Perspectives: The ISPOR Drug Cost Task Force Report—Part IV

✍ C. Daniel Mullins; Brian Seal; Enrique Seoane-Vazquez; Jayashri Sankaranarayanan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

The ISPOR Good Practices for Quality Imp

The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report

✍ William F. McGhan; Maiwenn Al; Jalpa A. Doshi; Isao Kamae; Steven E. Marx; Donna 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 226 KB